INOZYME PHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year Three
INOZYME PHARMA, INC. had Lessee, Operating Lease, Liability, to be Paid, Year Three of $944.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2023-03-22
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $944.00K.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $944.00K.
- 2022-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $944.00K.
- 2022-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $944.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2022-12-31 | $944.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $944.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $944.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $944.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.02M 10-K · filed 2022-03-15 |
| 2021-09-30 | $1.02M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.02M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.02M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $992.00K 10-K · filed 2021-03-25 |
| 2020-09-30 | $994.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $997.00K 10-Q · filed 2020-09-03 |